Valter Silva Monteiro

6 days ago | nature.com | Connor B Grady |Bornali Bhattacharjee |Julio César Silva |Júlio Silva |Valter Silva Monteiro |Mitsuaki Sawano | +3 more

AbstractThe symptomatic and immune responses to COVID-19 vaccination of people with Long COVID are poorly characterized. In this prospective study, we evaluated changes in symptoms and immune responses after COVID-19 vaccination in 16 vaccine-naïve individuals with Long COVID. Surveys were administered before vaccination and at 2, 6, and 12 weeks after receiving the first vaccine dose of the primary series.

Sep 25, 2023 | nature.com | Jon Klein |Rahul Dhodapkar |Peiwen Lu |Valter Silva Monteiro |Julio César Silva |Júlio Silva | +16 more

AbstractPost-acute infection syndromes may develop after acute viral disease1. Infection with SARS-CoV-2 can result in the development of a post-acute infection syndrome known as long COVID. Individuals with long COVID frequently report unremitting fatigue, post-exertional malaise, and a variety of cognitive and autonomic dysfunctions2,3,4. However, the biological processes that are associated with the development and persistence of these symptoms are unclear.